Al-Hamadi Trading is a term frequently mentioned among followers of the Saudi stock market, especially within the rapidly growing healthcare sector in the Kingdom. Al-Hamadi Holding, whose shares are traded on the Saudi "Tadawul" market under the symbol 4007, has become a prominent name in providing medical services and hospital management in Riyadh and its suburbs. This article highlights everything an investor or interested party needs to know about Al-Hamadi Trading, starting with an introduction to the company and its history, through key financial indicators, and reaching its policies on dividend distribution and future plans. We will also cover an analysis of its position within the healthcare sector and the role of Saudi Vision 2030 in driving its growth and competitiveness. It is important to note that this article fully complies with the regulations of the Capital Market Authority, as it does not include any recommendations or price forecasts, but aims to provide educational and objective content to give the reader an in-depth understanding of Al-Hamadi Trading and its role in the Saudi financial market. If you are looking for a reliable and in-depth analysis of Al-Hamadi's stock, you will find the answers to satisfy your curiosity here, with a constant invitation to consult a licensed financial advisor before making any investment decisions.
Overview of Al-Hamadi Holding and Its Activities
Al-Hamadi Holding was established as one of the leading Saudi companies specialized in the healthcare sector. Its headquarters is located in Riyadh, and it currently manages two major hospitals in the capital, which include over 600 beds and 180 outpatient clinics, with future plans to open two new hospitals within the next six years. The company focuses on providing medical services to international standards and developing healthcare infrastructure in line with the Kingdom's transformations towards a higher quality of life. Al-Hamadi has a proven track record of expansion and development, with continuous investment in human resources and modern medical technologies, making it a preferred choice for those seeking comprehensive and advanced healthcare services in a growing competitive environment.
Al-Hamadi Trading Stock: Symbol, Sector, and Trading Environment
Al-Hamadi Holding's stock is listed on the Saudi financial market (Tadawul) under the symbol 4007 and is classified within the healthcare services sector. The stock has shown relatively stable performance in recent years, influenced by the company's quarterly results and changes in the Saudi healthcare sector. Trading the stock allows investors to monitor developments in the healthcare sector and benefit from the company's financial performance, with the ability to view the latest prices and stock movements through the official Tadawul platform or accredited financial data platforms.
Al-Hamadi's Financial Performance: Revenues and Profits
Al-Hamadi Holding recorded significant growth in its financial performance recently. The company's revenues in 2022 increased by 17.9% to reach 1.122 billion Saudi Riyals compared to 952 million Riyals in 2021. The total profit amounted to 416 million Riyals, while operating profit reached 292 million Riyals and net profit was 257 million Riyals in the same year. These results reflect the company's ability to achieve sustainable growth and improve its operational efficiency, supported by expansion in capacity and enhancement of services provided. Strong financial indicators are a key factor in enhancing the stock's appeal to investors, especially in light of the regular dividend distribution policy.
Dividends at Al-Hamadi: Policy and History
Al-Hamadi Holding is committed to a policy of regular cash dividends to its shareholders, typically every quarter after the board's approval. The last official announcement regarding dividend distribution was in November 2025 for the third quarter of the fiscal year. This regular distribution policy reflects the company's success in achieving sustainable profits and its commitment to returning a portion of the returns to shareholders. Dividend distribution schedules and due dates can be monitored through quarterly reports or the company's official website and the Tadawul platform, making this policy a key attraction for investment funds and shareholders seeking regular income.
Analysis of the Saudi Healthcare Sector and Al-Hamadi's Position
The healthcare sector in the Kingdom is one of the fastest-growing and developing sectors under Vision 2030, with substantial government and private investments being pumped into developing infrastructure and medical services. Al-Hamadi competes in a highly competitive environment, with leading companies such as Dr. Suleiman Al-Habib Hospitals and Al-Mowasat Medical among others. Al-Hamadi's distinction lies in its ability to combine studied expansions with quality service, along with strategic partnerships that ensure its continuity and adaptation to modern technologies. The sector's shift towards digital healthcare services also enhances the company's growth opportunities and drives it to adopt the latest technological solutions.
Future Expansion Plans for Al-Hamadi Holding
Al-Hamadi aims to double its capacity by opening two new hospitals over the next six years, in addition to developing its outpatient clinics. These plans align with the Kingdom's Vision 2030, which encourages increasing bed capacity and improving the quality of healthcare services. Achieving these goals requires substantial capital investments and the development of human and technical resources. The expansions are expected to contribute to increasing the company's revenues and diversifying its services, in line with the growing demand for high-quality healthcare in Saudi Arabia.
Importance of Price-to-Earnings (P/E) Ratio and Stock Valuation
The price-to-earnings (P/E) ratio is one of the most important indicators used by investors to assess the attractiveness of Al-Hamadi's stock, calculated by dividing the market price of the stock by the announced earnings per share (EPS). A high P/E ratio reflects investors' expectations for the company's future earnings growth, especially in a thriving healthcare sector like the Saudi market. It is important to monitor quarterly changes in the P/E ratio and interpret the indicator within its proper context, comparing it with that of competing companies in the sector. For accurate valuation, it is always advisable to refer to the latest official financial reports.
The Role of Vision 2030 in Supporting Al-Hamadi's Growth
Al-Hamadi Holding has greatly benefited from Saudi Vision 2030, which has made the development of the healthcare sector a strategic goal. Government initiatives include improving the quality of healthcare, increasing bed capacity, and adopting digital technologies. These policies have supported an attractive investment environment for listed companies like Al-Hamadi, facilitating its expansion and attracting talent. Additionally, the company's presence on the "Tadawul" exchange gives it the ability to quickly raise new capital to support its expansion projects and update its infrastructure, enhancing its competitive position.
Comparing Al-Hamadi with Major Competitors in the Market
Al-Hamadi competes with major companies such as Dr. Suleiman Al-Habib Hospitals, Al-Mowasat Medical, and other specialized healthcare entities. Al-Hamadi differentiates itself with its gradual expansion approach and quality service, while some competitors resort to rapid geographical expansion or focus on specific medical specialties. Evaluating financial performance, expansion policies, and profitability ratios are among the key factors that highlight the strengths and weaknesses of each company. Competition remains a continuous driver for innovation and service development among all players in the sector.
How to Monitor Al-Hamadi's Stock Price and Market Value
The price of Al-Hamadi's stock can be monitored in real-time through the official Saudi Tadawul platform, where prices are updated live during trading sessions. Specialized financial data platforms such as Argaam and Arjam also allow monitoring of key stock indicators, such as market value, number of outstanding shares, and daily or annual change ratios. The market value reflects investor confidence in the company's performance and prospects, calculated by multiplying the stock price by the number of issued shares.
Latest News and Developments Regarding Al-Hamadi Trading
In November 2025, Al-Hamadi announced an important update regarding cash dividends for the third quarter, reflecting the continuation of its periodic distribution policy. The company is also continuing to implement its expansion plans to open two new hospitals and increase the number of beds and clinics. The latest developments can be accessed through the company's official website and investor relations channels, in addition to publications from the Saudi financial market. All indicators suggest that Al-Hamadi is keeping pace with sectoral transformations and investing in updating medical services to meet increasing demand.
Sources of Financial Data and Official Reports for Al-Hamadi
Financial data and detailed performance reports for Al-Hamadi are available on the company's official website in the investor relations section, as well as on the Saudi Tadawul platform, which provides updated quarterly and annual reports. These sources allow for reviewing the latest financial results, dividend distributions, and news of administrative and operational expansion. It is advisable to rely on these official sources for accurate and reliable information, with the option to follow economic press releases and specialized websites analyzing the performance of listed companies.
Regulatory Considerations and the Importance of Financial Consultation
It is important to emphasize that all information provided about Al-Hamadi Trading in this article is for educational and analytical purposes only, without offering investment advice or buy/sell recommendations. All trading operations in the Saudi financial market are supervised by the Capital Market Authority and are subject to strict regulatory procedures aimed at protecting investors and ensuring transparency. Therefore, it is always recommended to consult a licensed financial advisor before making any decisions related to stock trading or investing in the healthcare sector in general.
Conclusion
In conclusion, it is clear that Al-Hamadi Trading represents an advanced model for Saudi healthcare companies that have successfully achieved sustainable financial and operational growth, coinciding with the major transformations taking place in the sector under Saudi Vision 2030. With a well-studied expansion strategy, a clear dividend distribution policy, and strong financial indicators, Al-Hamadi maintains its leading position among companies listed in the Saudi financial market. As developments in the healthcare sector continue, monitoring official financial reports and company news remains a crucial step in understanding the dynamics of the stock and its position in the market. As always, the SIGMIX platform emphasizes the importance of consulting a certified financial advisor before making any investment decisions to ensure a thorough study of risks and opportunities according to each investor's personal goals.
Frequently Asked Questions
Al-Hamadi Holding's stock is traded on the Saudi financial market (Tadawul) under the symbol 4007. You can monitor the stock's performance and developments directly through the official Tadawul platform or specialized financial websites that provide updated data on stock prices and related financial indicators.
Al-Hamadi Holding has witnessed significant revenue growth in recent years, with revenues increasing by 17.9% in 2022 to reach 1.122 billion Saudi Riyals compared to 952 million Riyals in 2021. This growth reflects the improvement in demand for medical services and the expansion of the capacity of the hospitals managed by the company.
Al-Hamadi Holding follows a policy of regular cash dividends, typically on a quarterly basis after board approval. Through this policy, the company aims to reward shareholders for their investments and stimulate financial stability, with the ability to view the value of distributions and due dates through quarterly financial reports or the company's official website.
Several factors support Al-Hamadi's growth, including the continuous expansion of the number of hospitals and beds, investment in modern medical technologies, benefiting from Vision 2030 initiatives, and following partnership strategies with local and international entities. Additionally, the increasing demand for high-quality healthcare services in Saudi Arabia enhances the company's growth opportunities.
You can follow the latest news about Al-Hamadi Holding and developments regarding its stock through the company's official website in the investor relations section, as well as the Saudi Tadawul platform. Specialized economic websites and press reports also provide coverage of the latest financial results, expansion decisions, and dividend distributions.
The price-to-earnings (P/E) ratio is calculated by dividing the market price of the stock by the announced earnings per share (EPS). This indicator is an important reference for assessing the attractiveness of the stock and should be monitored periodically based on recent financial reports, comparing it with that of other healthcare companies.
Al-Hamadi competes with major companies such as Dr. Suleiman Al-Habib Hospitals, Al-Mowasat Medical, and other entities in the healthcare sector. Each competitor differs in its expansion strategy and focus on specific medical or geographical specialties, enhancing competitiveness and driving innovation and service development.
Al-Hamadi has benefited from government initiatives under Vision 2030 that aim to develop the healthcare sector by improving service quality, increasing investments, and adopting modern technologies. This support has helped the company implement its expansion plans and attract talent, positively reflecting on its financial and operational performance.
Like any stock investment, there are risks associated with trading Al-Hamadi's stock, including price volatility, regulatory changes, intense competition in the healthcare sector, and fluctuations in demand for medical services. Therefore, it is essential to study these factors carefully and consult specialists before making an investment decision.
Al-Hamadi provides its quarterly and annual financial reports through its official website, particularly in the investor relations section. Updated financial data can also be accessed through the Saudi Tadawul platform and specialized economic websites.
The SIGMIX platform provides educational content and neutral analysis of Al-Hamadi's stock performance, focusing on explaining financial indicators, company policies, and developments without offering investment recommendations. The platform allows investors and interested parties to understand the dynamics of the stock and its role in the Saudi market reliably and objectively.
Consulting a licensed financial advisor allows investors to assess risks and opportunities based on their personal goals and financial situation. The specialist helps analyze financial data and determine suitable strategies, contributing to informed and responsible decision-making, especially in dynamic sectors like healthcare.